Correlation Between Bone Biologics and Novacyt SA

Can any of the company-specific risk be diversified away by investing in both Bone Biologics and Novacyt SA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bone Biologics and Novacyt SA into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bone Biologics Corp and Novacyt SA, you can compare the effects of market volatilities on Bone Biologics and Novacyt SA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bone Biologics with a short position of Novacyt SA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bone Biologics and Novacyt SA.

Diversification Opportunities for Bone Biologics and Novacyt SA

0.78

Correlation Coefficient

Bone Biologics  Novacyt SA

Poor diversification

The 3 months correlation between Bone and Novacyt is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Bone Biologics Corp and Novacyt SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novacyt SA and Bone Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bone Biologics Corp are associated (or correlated) with Novacyt SA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novacyt SA has no effect on the direction of Bone Biologics i.e., Bone Biologics and Novacyt SA go up and down completely randomly.

Pair Corralation between Bone Biologics and Novacyt SA

Given the investment horizon of 90 days Bone Biologics Corp is expected to under-perform the Novacyt SA. In addition to that, Bone Biologics is 1.89 times more volatile than Novacyt SA. It trades about -0.02 of its total potential returns per unit of risk. Novacyt SA is currently generating about -0.01 per unit of volatility. If you would invest  160.00  in Novacyt SA on September 21, 2024 and sell it today you would lose (96.00) from holding Novacyt SA or give up 60.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	99.8%
Values	Daily Returns

Bone Biologics Corp  vs.  Novacyt SA

Bone Biologics Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Bone Biologics Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's essential indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Novacyt SA

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Novacyt SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with Bone Biologics and Novacyt SA

The main advantage of trading using opposite Bone Biologics and Novacyt SA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bone Biologics position performs unexpectedly, Novacyt SA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novacyt SA will offset losses from the drop in Novacyt SA's long position.

The idea behind Bone Biologics Corp and Novacyt SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.